IHC Any Single Marker (HER2/Neu, C4D, EBER, Ki67) Test
Comprehensive Immunohistochemistry Analysis for Precise Cancer Diagnosis
The IHC Any Single Marker test represents a cutting-edge approach in cancer diagnostics, utilizing advanced immunohistochemistry techniques to detect specific protein markers that play crucial roles in cancer development and progression. This specialized test focuses on key biomarkers including HER2/Neu, C4D, EBER, and Ki67, providing healthcare providers with essential information for accurate diagnosis and personalized treatment planning.
What Does the IHC Any Single Marker Test Measure?
This sophisticated diagnostic test detects and quantifies specific protein expressions in tissue samples through immunohistochemistry staining. The test targets four critical biomarkers:
- HER2/Neu: A growth-promoting protein found on some cancer cells, particularly important in breast and gastric cancers
- C4D: A complement component used in transplant pathology and autoimmune disease evaluation
- EBER: Epstein-Barr virus-encoded RNA, crucial for detecting EBV-associated malignancies
- Ki67: A proliferation marker that indicates how quickly cancer cells are dividing
Who Should Consider This Test?
This test is particularly recommended for patients experiencing or diagnosed with:
- Suspected or confirmed cancer cases requiring biomarker identification
- Breast cancer patients needing HER2 status determination
- Transplant recipients requiring rejection monitoring
- Patients with suspected EBV-associated lymphomas or nasopharyngeal carcinomas
- Individuals needing tumor proliferation rate assessment
- Patients requiring targeted therapy planning
Key Benefits of IHC Any Single Marker Testing
- Precise Diagnosis: Provides accurate identification of specific protein markers essential for cancer classification
- Treatment Guidance: Helps determine eligibility for targeted therapies like Herceptin for HER2-positive cancers
- Prognostic Information: Ki67 levels indicate tumor aggressiveness and growth potential
- Rapid Results: Complete analysis delivered within 3 business days
- Minimal Sample Requirement: Uses existing tissue samples without additional invasive procedures
Understanding Your Test Results
Your IHC Any Single Marker test results will provide detailed information about protein expression patterns:
- HER2/Neu Results: Scored from 0 to 3+, with 3+ indicating HER2-positive status suitable for targeted therapy
- Ki67 Index: Percentage of positive cells indicating proliferation rate (low: <20%, high: >20%)
- EBER Status: Positive or negative for Epstein-Barr virus association
- C4D Staining: Pattern and intensity relevant to transplant rejection or autoimmune conditions
All results are interpreted by board-certified pathologists and include comprehensive clinical correlation to ensure accurate understanding and appropriate next steps.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $112 |
| Regular Price | $150 |
Convenient Testing Across the United States
We have established branches in all major cities across the USA, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our nationwide network ensures accessible, high-quality diagnostic services with consistent standards of excellence.
Ready to schedule your IHC Any Single Marker test? Contact our dedicated healthcare team today at +1(267) 388-9828 to book your appointment or discuss your testing needs. Our specialists are available to answer your questions and guide you through the testing process.
Note: This test requires a doctor’s prescription for most cases. Prescription requirements do not apply to surgery and pregnancy cases or individuals planning international travel.
